Sumitomo Mitsui Trust Group
EBS icon

Sumitomo Mitsui Trust Group’s Emergent Biosolutions EBS Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,814
Closed -$164K – 1140
2023
Q1 		$164K Sell
15,814
-10,685
-40% -$129K ﹤0.01% 1139
2022
Q4 		$313K Buy
26,499
+6,935
+35% +$107K ﹤0.01% 1143
2022
Q3 		$411K Buy
19,564
+25
+0.1% +$696 ﹤0.01% 1142
2022
Q2 		$606K Buy
+19,539
New +$667K ﹤0.01% 1100

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sumitomo Mitsui Trust Group's EBS Position: Q2 2023 in Review

Sumitomo Mitsui Trust Group sold out of Emergent Biosolutions (EBS) in Q2 2023, closing a stake of 15,814 shares — an estimated $164K sold.

Sumitomo Mitsui Trust Group first reported a position in EBS in Q2 2022 and held it in 4 quarters. The position peaked at $606K in Q2 2022. 183 funds tracked by Wall St. Rank hold EBS as of Q2 2023.

  • Sumitomo Mitsui Trust Group reported no remaining Emergent Biosolutions position as of Q2 2023 after selling out during the quarter.
  • Sumitomo Mitsui Trust Group sold 15,814 Emergent Biosolutions shares in Q2 2023, an estimated $164K.
  • Sumitomo Mitsui Trust Group first reported a position in Emergent Biosolutions in Q2 2022 and held it in 4 quarters.
  • Sumitomo Mitsui Trust Group's Emergent Biosolutions position peaked at $606K in Q2 2022.
  • 183 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2023.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2023, filed 31 Jul 2023.